Status: Recruiting
Evaluate the Efficacy and Safety of Amino Acid (15) Peritoneal Dialysis Solution in Peritoneal Dialysis Patients with Malnutrition.
This is a multicenter, randomized, parallel controlled Phase IV clinical study to evaluate the safety and efficacy of amino acid (15) peritoneal dialysis solution in patients undergoing peritoneal dialysis with malnutrition in CAPD patients undergoing peritoneal dialysis maintenance.
Participants needed: 400
Trial details
Phase: Phase 4Age: 18-75Biological sex: AllType: InterventionalSponsor: Chengdu Qingshan Likang Pharmaceutical Co., LtdUpdated: Dec 30, 2024Locations: 21
Eligibility criteria
18 to 75 years of age (including 18 and 75 years of age), regardless of sex; [+6]
Within the past 3 months prior to the screening period, there has been a history... [+12]